Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis

Journal Title: The AAPS Journal - Year 2014, Vol 16, Issue 6

Abstract

The online version of this article (doi:10.1208/s12248-014-9671-y) contains supplementary material, which is available to authorized users.

Authors and Affiliations

Laura Northrup, Joshua O. Sestak, Bradley P. Sullivan, Sharadvi Thati, Brittany L. Hartwell, Teruna J. Siahaan, Charlotte M. Vines, Cory Berkland

Keywords

Related Articles

Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas

The online version of this article (doi:10.1208/s12248-012-9350-9) contains supplementary material, which is available to authorized users.

Pharmacokinetics/pharmacodynamics and the stages of drug development: Role of modeling and simulation

Pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation (M&S) are well-recognized powerful tools that enable effective implementation of the learn-and-confirm paradigm in drug development. The impac...

Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside

In recent years, there has been increasing interest in the development of medical decision-support tools, including dashboard systems. Dashboard systems are software packages that integrate information and calculations a...

Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

CT-P13, the world’s first biosimilar monoclonal antibody to infliximab, was approved for marketing in South Korea for all the six indications of infliximab, which Europe may follow, although the product was teste...

Erratum to: Translational Biomarkers: from Preclinical to Clinical a Report of 2009 AAPS/ACCP Biomarker Workshop

The online version of the original article can be found at 10.1208/s12248-011-9265-x.

Download PDF file
  • EP ID EP681728
  • DOI  10.1208/s12248-014-9671-y
  • Views 107
  • Downloads 0

How To Cite

Laura Northrup, Joshua O. Sestak, Bradley P. Sullivan, Sharadvi Thati, Brittany L. Hartwell, Teruna J. Siahaan, Charlotte M. Vines, Cory Berkland (2014). Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis. The AAPS Journal, 16(6), -. https://www.europub.co.uk/articles/-A-681728